Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
82204063, 11971117, and 11571082)
presence of hypoglycemia unawareness
There are a number of these medications currently available, some of which include: Semaglutide injection (Ozempic) Semaglutide injection (Wegovy) Semaglutide tablets (Rybelsus) Dulaglutide (Trulicity) Exenatide (Byetta) Exenatide extended-release (Bydureon) Liraglutide (Victoza) Lixisenatide (Adlyxin) Tirzepatide injection (Mounjaro) Source [1] Global GLP-1 receptor agonist market In 2024, the global GLP-1 receptor agonist market size was valued at an estimated USD 53.46 billion and is projected to reach USD 156.71 billion by 2030, with a Compound Annual Growth Rate (CAGR) of 17.46% between 2025 and 2030
To view or add a comment, sign in More Relevant Posts The next generation of GLP-1 therapies is here
US$ 27.07
US$ 24.67
US$ 26.91
US$ 26.66
US$ 28.61
